Human PELI1 adenoviral particles

PELI1 (Pellino E3 ubiquitin protein ligase 1) is a key gene encoding a member of the Pellino E3 ubiquitin ligase family, which plays a key role in regulating innate immune responses, inflammation, and cell signaling pathways. As an important component of the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling cascades, PELI1 mediates ubiquitination and degradation of key substrates, thereby regulating NF-κB and MAPK activation. PELI1 is involved in immune regulation, making it an important target for the study of autoimmune diseases, cancer, and infectious diseases. Studies have shown that PELI1 can promote or inhibit tumorigenesis depending on the cellular context, highlighting its dual role in disease progression.

Human PELI1 adenoviral particles are genetically engineered viral vectors designed to deliver the PELI1 gene to target cells for overexpression studies. These particles are based on replication-defective adenoviruses and can effectively transduce a variety of cell types, including primary cells and cells that are difficult to transfect. The high transduction efficiency and stable transgene expression of this adenoviral system make it an ideal tool for studying the functional role of PELI1 in vitro and in vivo. These particles are routinely purified and titrated to ensure consistent performance with minimal cytotoxicity. Researchers have used human PELI1 adenoviral particles to explore the impact of PELI1 on immune regulation, cancer progression, and other pathological conditions.